The effect of vitamin C administration on the Consumption of blood products in patients undergoing open heart surgery in two groups of tranexamine and vitC+tranexamine (randomized clinical trial)

Not Applicable

Recruiting

• Conditions: Haemorrhagic condition in open heart surgery.; Hemorrhagic condition, unspecified; D69.9

• Registration Number: IRCT20230607058400N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Age between 30-80 years
EF>30%
BMI<26
written informed consent
no history of drug sensitivity
first heart surgery
no history of disorders and coagulation factors
hemoglobin more than 10 gr/dl

Exclusion Criteria

Dissatisfaction and willingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of blood loss during and after surgery. Timepoint: at Hour 0, 2, 4, 6, 8, 10, 12. Method of measurement: visual estimation of blood loss in bottles.

Secondary Outcome Measures

Name	Time	Method
Measuring length of stay in ICU. Timepoint: Days of hospitalization in the ICU. Method of measurement: number of days.;Measuring length of stay in hospital. Timepoint: Days of hospitalization in hospital. Method of measurement: number of days.;Measuring the amount of hemoglobin drop. Timepoint: after surgery. Method of measurement: blood test.